Amyloid angiopathy in diffuse lewy body disease

E. Wu, Richard B. Lipton, Dennis W. Dickson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Article abstract We determined the frequency of cerebral amyloid angiopathy (CAA) in 135 consecutive cases of diffuse Lewy body disease (DLBD) (N = 67), Alzheimer's disease (AD) (N = 34), and normal elderly controls (NECs) (N = 34). DLBD cases were subdivided into those with pathologic changes compatible with coexistent AD (DLBD/AD) and those without sufficient AD–type changes to warrant that diagnosis. In each case, we assessed the frequency, severity, and distribution of CAA on multiple thioflavin–S–stained sections of cerebral cortex examined with fluorescent microscopy. Based on immunocytochemistry with βT–amyloid antibodies, amyloid in all the brains was composed of βT/A4. CAA was present in the leptomeningeal vessels in 50% of the NECs and in 100% of AD cases. In DLBD without coexisting AD, the frequency of leptomeningeal CAA was 58%, whereas in DLBD/AD, the frequency was 85%. The frequency of CAA in parenchymal vessels was 38% for NECs, 97% for AD, 43% for DLBD, and 85% for DLBD/AD. There was no significant difference in the frequency or severity of CAA between NECs and DLBD, but CAA was significantly more severe, and comparable with CAA in AD, in the cases of DLBD/AD. Ten NECs had focal CAA without senile plaques (SPs), whereas all other cases with CAA had at least some SPs. Neither CAA nor SPs were present in 14 cases, including seven NECs and seven DLBD cases. We found cerebrovascular accidents in 50 cases (including nine without CAA) and leukoencephalopathy in 24 cases. These results suggest that CAA and other AD–type changes are not concomitant with DLBD but are related to coexisting AD or pathologic aging.

Original languageEnglish (US)
Pages (from-to)2131-2135
Number of pages5
JournalNeurology
Volume42
Issue number11
StatePublished - 1992

Fingerprint

Cerebral Amyloid Angiopathy
Lewy Body Disease
Alzheimer Disease
Amyloid Plaques
Amyloid angiopathy
Alzheimer's Disease
Leukoencephalopathies
Amyloid
Cerebral Cortex

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Wu, E., Lipton, R. B., & Dickson, D. W. (1992). Amyloid angiopathy in diffuse lewy body disease. Neurology, 42(11), 2131-2135.

Amyloid angiopathy in diffuse lewy body disease. / Wu, E.; Lipton, Richard B.; Dickson, Dennis W.

In: Neurology, Vol. 42, No. 11, 1992, p. 2131-2135.

Research output: Contribution to journalArticle

Wu, E, Lipton, RB & Dickson, DW 1992, 'Amyloid angiopathy in diffuse lewy body disease', Neurology, vol. 42, no. 11, pp. 2131-2135.
Wu, E. ; Lipton, Richard B. ; Dickson, Dennis W. / Amyloid angiopathy in diffuse lewy body disease. In: Neurology. 1992 ; Vol. 42, No. 11. pp. 2131-2135.
@article{97cb27a8c97f4c1aac6783850c9bd886,
title = "Amyloid angiopathy in diffuse lewy body disease",
abstract = "Article abstract We determined the frequency of cerebral amyloid angiopathy (CAA) in 135 consecutive cases of diffuse Lewy body disease (DLBD) (N = 67), Alzheimer's disease (AD) (N = 34), and normal elderly controls (NECs) (N = 34). DLBD cases were subdivided into those with pathologic changes compatible with coexistent AD (DLBD/AD) and those without sufficient AD–type changes to warrant that diagnosis. In each case, we assessed the frequency, severity, and distribution of CAA on multiple thioflavin–S–stained sections of cerebral cortex examined with fluorescent microscopy. Based on immunocytochemistry with βT–amyloid antibodies, amyloid in all the brains was composed of βT/A4. CAA was present in the leptomeningeal vessels in 50{\%} of the NECs and in 100{\%} of AD cases. In DLBD without coexisting AD, the frequency of leptomeningeal CAA was 58{\%}, whereas in DLBD/AD, the frequency was 85{\%}. The frequency of CAA in parenchymal vessels was 38{\%} for NECs, 97{\%} for AD, 43{\%} for DLBD, and 85{\%} for DLBD/AD. There was no significant difference in the frequency or severity of CAA between NECs and DLBD, but CAA was significantly more severe, and comparable with CAA in AD, in the cases of DLBD/AD. Ten NECs had focal CAA without senile plaques (SPs), whereas all other cases with CAA had at least some SPs. Neither CAA nor SPs were present in 14 cases, including seven NECs and seven DLBD cases. We found cerebrovascular accidents in 50 cases (including nine without CAA) and leukoencephalopathy in 24 cases. These results suggest that CAA and other AD–type changes are not concomitant with DLBD but are related to coexisting AD or pathologic aging.",
author = "E. Wu and Lipton, {Richard B.} and Dickson, {Dennis W.}",
year = "1992",
language = "English (US)",
volume = "42",
pages = "2131--2135",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Amyloid angiopathy in diffuse lewy body disease

AU - Wu, E.

AU - Lipton, Richard B.

AU - Dickson, Dennis W.

PY - 1992

Y1 - 1992

N2 - Article abstract We determined the frequency of cerebral amyloid angiopathy (CAA) in 135 consecutive cases of diffuse Lewy body disease (DLBD) (N = 67), Alzheimer's disease (AD) (N = 34), and normal elderly controls (NECs) (N = 34). DLBD cases were subdivided into those with pathologic changes compatible with coexistent AD (DLBD/AD) and those without sufficient AD–type changes to warrant that diagnosis. In each case, we assessed the frequency, severity, and distribution of CAA on multiple thioflavin–S–stained sections of cerebral cortex examined with fluorescent microscopy. Based on immunocytochemistry with βT–amyloid antibodies, amyloid in all the brains was composed of βT/A4. CAA was present in the leptomeningeal vessels in 50% of the NECs and in 100% of AD cases. In DLBD without coexisting AD, the frequency of leptomeningeal CAA was 58%, whereas in DLBD/AD, the frequency was 85%. The frequency of CAA in parenchymal vessels was 38% for NECs, 97% for AD, 43% for DLBD, and 85% for DLBD/AD. There was no significant difference in the frequency or severity of CAA between NECs and DLBD, but CAA was significantly more severe, and comparable with CAA in AD, in the cases of DLBD/AD. Ten NECs had focal CAA without senile plaques (SPs), whereas all other cases with CAA had at least some SPs. Neither CAA nor SPs were present in 14 cases, including seven NECs and seven DLBD cases. We found cerebrovascular accidents in 50 cases (including nine without CAA) and leukoencephalopathy in 24 cases. These results suggest that CAA and other AD–type changes are not concomitant with DLBD but are related to coexisting AD or pathologic aging.

AB - Article abstract We determined the frequency of cerebral amyloid angiopathy (CAA) in 135 consecutive cases of diffuse Lewy body disease (DLBD) (N = 67), Alzheimer's disease (AD) (N = 34), and normal elderly controls (NECs) (N = 34). DLBD cases were subdivided into those with pathologic changes compatible with coexistent AD (DLBD/AD) and those without sufficient AD–type changes to warrant that diagnosis. In each case, we assessed the frequency, severity, and distribution of CAA on multiple thioflavin–S–stained sections of cerebral cortex examined with fluorescent microscopy. Based on immunocytochemistry with βT–amyloid antibodies, amyloid in all the brains was composed of βT/A4. CAA was present in the leptomeningeal vessels in 50% of the NECs and in 100% of AD cases. In DLBD without coexisting AD, the frequency of leptomeningeal CAA was 58%, whereas in DLBD/AD, the frequency was 85%. The frequency of CAA in parenchymal vessels was 38% for NECs, 97% for AD, 43% for DLBD, and 85% for DLBD/AD. There was no significant difference in the frequency or severity of CAA between NECs and DLBD, but CAA was significantly more severe, and comparable with CAA in AD, in the cases of DLBD/AD. Ten NECs had focal CAA without senile plaques (SPs), whereas all other cases with CAA had at least some SPs. Neither CAA nor SPs were present in 14 cases, including seven NECs and seven DLBD cases. We found cerebrovascular accidents in 50 cases (including nine without CAA) and leukoencephalopathy in 24 cases. These results suggest that CAA and other AD–type changes are not concomitant with DLBD but are related to coexisting AD or pathologic aging.

UR - http://www.scopus.com/inward/record.url?scp=0026452997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026452997&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 2131

EP - 2135

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -